Related Content
Search Google Scholar for:
|
|
Science 13 March 1992: Vol. 255. no. 5050, pp. 1434 - 1437 DOI: 10.1126/science.1542794
|
|
Articles
Science, Vol 255, Issue 5050, 1434-1437
Copyright © 1992 by American Association for the Advancement of Science
The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor
DP Gearing,
MR Comeau,
DJ Friend,
SD Gimpel,
CJ Thut,
J McGourty,
KK Brasher,
JA King,
S Gillis,
B Mosley,
and
al. et
Immunex Research and Development Corporation, Seattle, WA 98101.
Leukemia inhibitory factor (LIF) and interleukin-6 (IL-6) are multifunctional cytokines with many similar activities. LIF is structurally and functionally related to another cytokine, Oncostatin M (OSM), that binds to the high-affinity LIF receptor but not to the low-affinity LIF receptor. A complementary DNA was isolated that encodes the high-affinity converting subunit of the LIF receptor. The converter conferred high-affinity binding of both LIF and OSM when expressed with the low-affinity LIF receptor and is identical to the signal transducing subunit of the IL-6 receptor, gp130. The gp130 subunit alone confers low-affinity binding of OSM when expressed in COS-7 cells. This receptor system resembles the high-affinity receptors for granulocyte-macrophage colony-stimulating factor, IL-3, and IL-5, which share a common subunit.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Ciliary Neurotrophic Factor Stimulates Muscle Glucose Uptake by a PI3-Kinase-Dependent Pathway That Is Impaired With Obesity.
- G. R. Steinberg, M. J. Watt, M. Ernst, M. J. Birnbaum, B. E. Kemp, and S. B. Jorgensen (2009)
Diabetes
58, 829-839
| Abstract »
| Full Text »
| PDF »
- A Genetic Expression Profile Associated with Oral Cancer Identifies a Group of Patients at High Risk of Poor Survival.
- E. Mendez, J. R. Houck, D. R. Doody, W. Fan, P. Lohavanichbutr, T. C. Rue, B. Yueh, N. D. Futran, M. P. Upton, D. G. Farwell, et al. (2009)
Clin. Cancer Res.
15, 1353-1361
| Abstract »
| Full Text »
| PDF »
- Neurogenesis in the Dentate Gyrus Depends on Ciliary Neurotrophic Factor and Signal Transducer and Activator of Transcription 3 Signaling.
- S. Muller, B. P.S. Chakrapani, H. Schwegler, H.-D. Hofmann, and M. Kirsch (2009)
Stem Cells
27, 431-441
| Abstract »
| Full Text »
| PDF »
- Mice Overexpressing Murine Oncostatin M (OSM) Exhibit Changes in Hematopoietic and Other Organs that Are Distinct from Those of Mice Overexpressing Human OSM or Bovine OSM.
- T.S.-C. Juan, B. Bolon, R. A. Lindberg, Y. Sun, G. Van, and F. A. Fletcher (2009)
Vet. Pathol.
46, 124-137
| Abstract »
| Full Text »
| PDF »
- Mechanisms of Oncostatin M-Induced Pulmonary Inflammation and Fibrosis.
- A. Mozaffarian, A. W. Brewer, E. S. Trueblood, I. G. Luzina, N. W. Todd, S. P. Atamas, and H. A. Arnett (2008)
J. Immunol.
181, 7243-7253
| Abstract »
| Full Text »
| PDF »
- The "Bubble Boy" Paradox: An Answer That Led to a Question.
- L. J. Berg (2008)
J. Immunol.
181, 5815-5816
| Full Text »
| PDF »
- Activation of Akt through gp130 Receptor Signaling Is Required for Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphatic Reprogramming of Endothelial Cells.
- V. A. Morris, A. S. Punjabi, and M. Lagunoff (2008)
J. Virol.
82, 8771-8779
| Abstract »
| Full Text »
| PDF »
- c-Cbl-Dependent Monoubiquitination and Lysosomal Degradation of gp130.
- Y. Tanaka, N. Tanaka, Y. Saeki, K. Tanaka, M. Murakami, T. Hirano, N. Ishii, and K. Sugamura (2008)
Mol. Cell. Biol.
28, 4805-4818
| Abstract »
| Full Text »
| PDF »
- Mutation of Prkar1a Causes Osteoblast Neoplasia Driven by Dysregulation of Protein Kinase A.
- E. Pavel, K. Nadella, W. H. Towns II, and L. S. Kirschner (2008)
Mol. Endocrinol.
22, 430-440
| Abstract »
| Full Text »
| PDF »
- Leukemia inhibitory factor ligand-receptor signaling is important for uterine receptivity and implantation in golden hamsters (Mesocricetus auratus).
- T. Ding, H. Song, X. Wang, A. Khatua, and B. C Paria (2008)
Reproduction
135, 41-53
| Abstract »
| Full Text »
| PDF »
- Oncostatin M Secreted by Skin Infiltrating T Lymphocytes Is a Potent Keratinocyte Activator Involved in Skin Inflammation.
- K. Boniface, C. Diveu, F. Morel, N. Pedretti, J. Froger, E. Ravon, M. Garcia, E. Venereau, L. Preisser, E. Guignouard, et al. (2007)
J. Immunol.
178, 4615-4622
| Abstract »
| Full Text »
| PDF »
- Characterization of the Interleukin (IL)-6 Inhibitor IL-6-RFP: FUSED RECEPTOR DOMAINS ACT AS HIGH AFFINITY CYTOKINE-BINDING PROTEINS.
- S. Metz, M. Wiesinger, M. Vogt, H. Lauks, G. Schmalzing, P. C. Heinrich, and G. Muller-Newen (2007)
J. Biol. Chem.
282, 1238-1248
| Abstract »
| Full Text »
| PDF »
- Molecular and Functional Characterization of a Soluble Form of Oncostatin M/Interleukin-31 Shared Receptor.
- C. Diveu, E. Venereau, J. Froger, E. Ravon, L. Grimaud, F. Rousseau, S. Chevalier, and H. Gascan (2006)
J. Biol. Chem.
281, 36673-36682
| Abstract »
| Full Text »
| PDF »
- Oncostatin M (OSM) Cytostasis of Breast Tumor Cells: Characterization of an OSM Receptor {beta}-Specific Kernel..
- N. Underhill-Day and J. K. Heath (2006)
Cancer Res.
66, 10891-10901
| Abstract »
| Full Text »
| PDF »
- Continued Administration of Ciliary Neurotrophic Factor Protects Mice from Inflammatory Pathology in Experimental Autoimmune Encephalomyelitis.
- T. Kuhlmann, L. Remington, I. Cognet, L. Bourbonniere, S. Zehntner, F. Guilhot, A. Herman, A. Guay-Giroux, J. P. Antel, T. Owens, et al. (2006)
Am. J. Pathol.
169, 584-598
| Abstract »
| Full Text »
| PDF »
- Loss of Leukemia Inhibitory Factor Receptor beta or Cardiotrophin-1 Causes Similar Deficits in Preganglionic Sympathetic Neurons and Adrenal Medulla.
- S. Oberle, A. Schober, V. Meyer, B. Holtmann, C. Henderson, M. Sendtner, and K. Unsicker (2006)
J. Neurosci.
26, 1823-1832
| Abstract »
| Full Text »
| PDF »
- Dimerization of the cytokine receptors gp130 and LIFR analysed in single cells.
- B. Giese, C. Roderburg, M. Sommerauer, S. B. Wortmann, S. Metz, P. C. Heinrich, and G. Muller-Newen (2005)
J. Cell Sci.
118, 5129-5140
| Abstract »
| Full Text »
| PDF »
- Cross-talk among gp130 Cytokines in Adipocytes.
- S. Zvonic, J. E. Baugh Jr., P. Arbour-Reily, R. L. Mynatt, and J. M. Stephens (2005)
J. Biol. Chem.
280, 33856-33863
| Abstract »
| Full Text »
| PDF »
- Evidence of a new leukemia inhibitory factor-associated genetic marker for litter size in a synthetic pig line.
- A. Spotter, C. Drogemuller, H. Hamann, and O. Distl (2005)
J Anim Sci
83, 2264-2270
| Abstract »
| Full Text »
| PDF »
- Mammary Gland Remodeling Depends on gp130 Signaling through Stat3 and MAPK.
- L. Zhao, S. Hart, J. Cheng, J. J. Melenhorst, B. Bierie, M. Ernst, C. Stewart, F. Schaper, P. C. Heinrich, A. Ullrich, et al. (2004)
J. Biol. Chem.
279, 44093-44100
| Abstract »
| Full Text »
| PDF »
- Signal transducer and activator of transcription 3 (Stat3) expression and activation in rat uterus during early pregnancy.
- C.-B. Teng, H.-L. Diao, H. Ma, J. Cong, H. Yu, X.-H. Ma, L.-B. Xu, and Z.-M. Yang (2004)
Reproduction
128, 197-205
| Abstract »
| Full Text »
| PDF »
- Chicken Leukemia Inhibitory Factor Maintains Chicken Embryonic Stem Cells in the Undifferentiated State.
- H. Horiuchi, A. Tategaki, Y. Yamashita, H. Hisamatsu, M. Ogawa, T. Noguchi, M. Aosasa, T. Kawashima, S. Akita, N. Nishimichi, et al. (2004)
J. Biol. Chem.
279, 24514-24520
| Abstract »
| Full Text »
| PDF »
- Pharmacokinetics of Recombinant Human Leukemia Inhibitory Factor in Sheep.
- A. M. Segrave, D. E. Mager, S. A. Charman, G. A. Edwards, and C. J. H. Porter (2004)
J. Pharmacol. Exp. Ther.
309, 1085-1092
| Abstract »
| Full Text »
| PDF »
- Polarity and lipid raft association of the components of the ciliary neurotrophic factor receptor complex in Madin-Darby canine kidney cells.
- D. M. Buk, M. Waibel, C. Braig, A. S. Martens, P. C. Heinrich, and L. Graeve (2004)
J. Cell Sci.
117, 2063-2075
| Abstract »
| Full Text »
| PDF »
- Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor.
- D. Derouet, F. Rousseau, F. Alfonsi, J. Froger, J. Hermann, F. Barbier, D. Perret, C. Diveu, C. Guillet, L. Preisser, et al. (2004)
PNAS
101, 4827-4832
| Abstract »
| Full Text »
| PDF »
- Affinity Maturation of Leukemia Inhibitory Factor and Conversion to Potent Antagonists of Signaling.
- W. D. Fairlie, A. D. Uboldi, J. E. McCoubrie, C. C. Wang, E. F. Lee, S. Yao, D. P. De Souza, S. Mifsud, D. Metcalf, N. A. Nicola, et al. (2004)
J. Biol. Chem.
279, 2125-2134
| Abstract »
| Full Text »
| PDF »
- GPL, a Novel Cytokine Receptor Related to GP130 and Leukemia Inhibitory Factor Receptor.
- C. Diveu, E. Lelievre, D. Perret, A.-H. L. Lak-Hal, J. Froger, C. Guillet, S. Chevalier, F. Rousseau, A. Wesa, L. Preisser, et al. (2003)
J. Biol. Chem.
278, 49850-49859
| Abstract »
| Full Text »
| PDF »
- Targeted disruption of oncostatin M receptor results in altered hematopoiesis.
- M. Tanaka, Y. Hirabayashi, T. Sekiguchi, T. Inoue, M. Katsuki, and A. Miyajima (2003)
Blood
102, 3154-3162
| Abstract »
| Full Text »
| PDF »
- Role of Monocytes in Atherogenesis.
- B. OSTERUD and E. BJORKLID (2003)
Physiol Rev
83, 1069-1112
| Abstract »
| Full Text »
| PDF »
- Leukemia Inhibitory Factor (LIF), Cardiotrophin-1, and Oncostatin M Share Structural Binding Determinants in the Immunoglobulin-like Domain of LIF Receptor.
- H. Plun-Favreau, D. Perret, C. Diveu, J. Froger, S. Chevalier, E. Lelievre, H. Gascan, and M. Chabbert (2003)
J. Biol. Chem.
278, 27169-27179
| Abstract »
| Full Text »
| PDF »
- A Phase I Study of Recombinant Human Leukemia Inhibitory Factor in Patients with Advanced Cancer.
- D. H. Gunawardana, R. L. Basser, I. D. Davis, J. Cebon, P. Mitchell, C. Underhill, T. J. Kilpatrick, K. Reardon, M. D. Green, P. Bardy, et al. (2003)
Clin. Cancer Res.
9, 2056-2065
| Abstract »
| Full Text »
| PDF »
- Cytokine Suppression of Dopamine-beta -hydroxylase by Extracellular Signal-regulated Kinase-dependent and -independent Pathways.
- S. Dziennis and B. A. Habecker (2003)
J. Biol. Chem.
278, 15897-15904
| Abstract »
| Full Text »
| PDF »
- Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential.
- J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen (2003)
Pharmacol. Rev.
55, 133-166
| Abstract »
| Full Text »
| PDF »
- Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130.
- M. Hayashi, M.-C. Rho, A. Enomoto, A. Fukami, Y.-P. Kim, Y. Kikuchi, T. Sunazuka, T. Hirose, K. Komiyama, and S. Omura (2002)
PNAS
99, 14728-14733
| Abstract »
| Full Text »
| PDF »
- Biological Activity of a Novel Nonpeptide Antagonist to the Interleukin-6 Receptor 20S,21-Epoxy-resibufogenin-3-formate.
- M. Hayashi, M.-C. Rho, A. Fukami, A. Enomoto, S. Nonaka, Y. Sekiguchi, T. Yanagisawa, A. Yamashita, T. Nogawa, Y. Kamano, et al. (2002)
J. Pharmacol. Exp. Ther.
303, 104-109
| Abstract »
| Full Text »
| PDF »
- Differential Toxicogenomic Responses to 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Malignant and Nonmalignant Human Airway Epithelial Cells.
- J. M. Martinez, C. A. Afshari, P. R. Bushel, A. Masuda, T. Takahashi, and N. J. Walker (2002)
Toxicol. Sci.
69, 409-423
| Abstract »
| Full Text »
| PDF »
- Ligand/Receptor Signaling Threshold (LIST) Model Accounts for gp130-Mediated Embryonic Stem Cell Self-Renewal Responses to LIF and HIL-6.
- S. Viswanathan, T. Benatar, S. Rose-John, D. A. Lauffenburger, and P. W. Zandstra (2002)
Stem Cells
20, 119-138
| Abstract »
| Full Text »
| PDF »
- Exclusive Neutrophil Recruitment with Oncostatin M in a Human System.
- S. M. Kerfoot, E. Raharjo, M. Ho, J. Kaur, S. Serirom, D.-M. McCafferty, A. R. Burns, K. D. Patel, and P. Kubes (2001)
Am. J. Pathol.
159, 1531-1539
| Abstract »
| Full Text »
- Menstrual cycle-specific inhibition of endometrial stromal cell proliferation by oncostatin M.
- Y. Ohata, T. Harada, A. Fujii, S. Yoshida, T. Iwabe, and N. Terakawa (2001)
Mol. Hum. Reprod.
7, 665-670
| Abstract »
| Full Text »
| PDF »
- Expression of interleukin-11 during the human menstrual cycle: coincidence with stromal cell decidualization and relationship to leukaemia inhibitory factor and prolactin.
- E. Dimitriadis, L.A. Salamonsen, and L. Robb (2000)
Mol. Hum. Reprod.
6, 907-914
| Abstract »
| Full Text »
| PDF »
- Signal Transduction of IL-6, Leukemia-Inhibitory Factor, and Oncostatin M: Structural Receptor Requirements for Signal Attenuation.
- D. Anhuf, M. Weissenbach, J. Schmitz, R. Sobota, H. M. Hermanns, S. Radtke, S. Linnemann, I. Behrmann, P. C. Heinrich, and F. Schaper (2000)
J. Immunol.
165, 2535-2543
| Abstract »
| Full Text »
| PDF »
- Leukemia Inhibitory Factor, Leukemia Inhibitory Factor Receptor, and Glycoprotein 130 in Rhesus Monkey Uterus During Menstrual Cycle and Early Pregnancy.
- Z.-P. Yue, Z.-M. Yang, P. Wei, S.-J. Li, H.-B. Wang, J.-H. Tan, and M. J.K. Harper (2000)
Biol Reprod
63, 508-512
| Abstract »
| Full Text »
- Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6.
- J.-J. Schuringa, A. T. J. Wierenga, W. Kruijer, and E. Vellenga (2000)
Blood
95, 3765-3770
| Abstract »
| Full Text »
| PDF »
- Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function.
- C. J. Auernhammer and S. Melmed (2000)
Endocr. Rev.
21, 313-345
| Abstract »
| Full Text »
- Leukemia Inhibitory Factor Modulates Cardiogenesis in Embryoid Bodies in Opposite Fashions.
- A. Bader, H. Al-Dubai, and G. Weitzer (2000)
Circ. Res.
86, 787-794
| Abstract »
| Full Text »
| PDF »
- Identification of a gp130 Cytokine Receptor Critical Site Involved in Oncostatin M Response.
- C. Olivier, P. Auguste, M. Chabbert, E. Lelievre, S. Chevalier, and H. Gascan (2000)
J. Biol. Chem.
275, 5648-5656
| Abstract »
| Full Text »
| PDF »
- Potential role of LIF as a modifier gene in the pathogenesis of amyotrophic lateral sclerosis.
- R. Giess, M. Beck, R. Goetz, R. M. Nitsch, K. V. Toyka, and M. Sendtner (2000)
Neurology
54, 1003-1005
| Abstract »
| Full Text »
| PDF »
- Studies on the Interleukin-6-type Cytokine Signal Transducer gp130 Reveal a Novel Mechanism of Receptor Activation by Monoclonal Antibodies.
- G. Muller-Newen, A. Kuster, J. Wijdenes, F. Schaper, and P. C. Heinrich (2000)
J. Biol. Chem.
275, 4579-4586
| Abstract »
| Full Text »
| PDF »
- Importance of the Membrane-Proximal Extracellular Domains for Activation of the Signal Transducer Glycoprotein 130.
- I. Kurth, U. Horsten, S. Pflanz, A. Timmermann, A. Kuster, H. Dahmen, I. Tacken, P. C. Heinrich, and G. Muller-Newen (2000)
J. Immunol.
164, 273-282
| Abstract »
| Full Text »
| PDF »
- Novel neurotrophin-1/B cell-stimulating factor-3: A cytokine of the IL-6 family.
- G. Senaldi, B. C. Varnum, U. Sarmiento, C. Starnes, J. Lile, S. Scully, J. Guo, G. Elliott, J. McNinch, C. L. Shaklee, et al. (1999)
PNAS
96, 11458-11463
| Abstract »
| Full Text »
| PDF »
- A Novel Oncostatin M-inducible Gene OIG37 Forms a Gene Family with MyD118 and GADD45 and Negatively Regulates Cell Growth.
- K. Nakayama, T. Hara, M. Hibi, T. Hirano, and A. Miyajima (1999)
J. Biol. Chem.
274, 24766-24772
| Abstract »
| Full Text »
| PDF »
- Oncostatin M Induces Angiogenesis In Vitro and In Vivo.
- M. Vasse, J. Pourtau, V. Trochon, M. Muraine, J.-P. Vannier, H. Lu, J. Soria, and C. Soria (1999)
Arterioscler. Thromb. Vasc. Biol.
19, 1835-1842
| Abstract »
| Full Text »
| PDF »
- Recruitment of a Heparan Sulfate Subunit to the Interleukin-1 Receptor Complex. REGULATION BY FIBRONECTIN ATTACHMENT.
- S. Valles, C. Tsoi, W.-Y. Huang, D. Wyllie, F. Carlotti, J. A. Askari, M. J. Humphries, S. K. Dower, and E. E. Qwarnstrom (1999)
J. Biol. Chem.
274, 20103-20109
| Abstract »
| Full Text »
| PDF »
- Interleukin-6 (IL-6) Production by Astrocytes: Autocrine Regulation by IL-6 and the Soluble IL-6 Receptor.
- N. J. Van Wagoner, J.-W. Oh, P. Repovic, and E. N. Benveniste (1999)
J. Neurosci.
19, 5236-5244
| Abstract »
| Full Text »
| PDF »
- Leukaemia inhibitory factor gene mutations in infertile women.
- R. Giess, I. Tanasescu, T. Steck, and M. Sendtner (1999)
Mol. Hum. Reprod.
5, 581-586
| Abstract »
| Full Text »
| PDF »
- Evaluation of the effect of interleukin-6 and human extracellullar matrix on embryonic development.
- N. Desai, M. Scarrow, J. Lawson, D. Kinzer, and J. Goldfarb (1999)
Hum. Reprod.
14, 1588-1592
| Abstract »
| Full Text »
| PDF »
- Binding of Leukemia Inhibitory Factor (LIF) to Mutants of Its Low Affinity Receptor, gp190, Reveals a LIF Binding Site Outside and Interactions between the Two Cytokine Binding Domains.
- J.-L. Taupin, V. Miossec, V. Pitard, F. Blanchard, S. Daburon, S. Raher, Y. Jacques, A. Godard, and J.-F. Moreau (1999)
J. Biol. Chem.
274, 14482-14489
| Abstract »
| Full Text »
| PDF »
- Critical Role for STAT3 in Murine Pituitary Adrenocorticotropin Hormone Leukemia Inhibitory Factor Signaling.
- C. Bousquet and S. Melmed (1999)
J. Biol. Chem.
274, 10723-10730
| Abstract »
| Full Text »
| PDF »
- Ciliary Neurotrophic Factor is a Regulator of Muscular Strength in Aging.
- C. Guillet, P. Auguste, W. Mayo, P. Kreher, and H. Gascan (1999)
J. Neurosci.
19, 1257-1262
| Abstract »
| Full Text »
| PDF »
- Localization of Leukemia Inhibitory Factor and Its Receptor in Human Placenta Throughout Pregnancy.
- A.M. Sharkey, A. King, D.E. Clark, T.D. Burrows, P.P. Jokhi, D.S. Charnock-Jones, Y.W. Loke, and S.K. Smith (1999)
Biol Reprod
60, 355-364
| Abstract »
| Full Text »
| PDF »
- Activation of the Signal Transducer Glycoprotein 130 by Both IL-6 and IL-11 Requires Two Distinct Binding Epitopes.
- I. Kurth, U. Horsten, S. Pflanz, H. Dahmen, A. Kuster, J. Grotzinger, P. C. Heinrich, and G. Muller-Newen (1999)
J. Immunol.
162, 1480-1487
| Abstract »
| Full Text »
| PDF »
- Reconstitution of the Functional Mouse Oncostatin M (OSM) Receptor: Molecular Cloning of the Mouse OSM Receptor beta Subunit.
- M. Tanaka, T. Hara, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and A. Miyajima (1999)
Blood
93, 804-815
| Abstract »
| Full Text »
| PDF »
- The Box-1 Region of the Leukemia Inhibitory Factor Receptor alpha -Chain Cytoplasmic Domain Is Sufficient for Hemopoietic Cell Proliferation and Differentiation.
- Y. Zhang, T. Willson, D. Metcalf, D. Cary, D. J. Hilton, R. Clark, and N. A. Nicola (1998)
J. Biol. Chem.
273, 34370-34383
| Abstract »
| Full Text »
| PDF »
- Functional Map of a Placenta-specific Enhancer of the Human Leukemia Inhibitory Factor Receptor Gene.
- Z. Wang and S. Melmed (1998)
J. Biol. Chem.
273, 26069-26077
| Abstract »
| Full Text »
| PDF »
- Reciprocal Regulation of Ciliary Neurotrophic Factor Receptors and Acetylcholine Receptors during Synaptogenesis in Embryonic Chick Atria.
- X. Wang and S. W. Halvorsen (1998)
J. Neurosci.
18, 7372-7380
| Abstract »
| Full Text »
| PDF »
- Leptin causes body weight loss in the absence of in vivo activities typical of cytokines of the IL-6 family.
- D. Agnello, C. Meazza, C. G. Rowan, P. Villa, P. Ghezzi, and G. Senaldi (1998)
Am J Physiol Regulatory Integrative Comp Physiol
275, R913-R919
| Abstract »
| Full Text »
| PDF »
- The Immunoglobulin-like Module of gp130 Is Required for Signaling by Interleukin-6, but Not by Leukemia Inhibitory Factor.
- A. Hammacher, R. T. Richardson, J. E. Layton, D. K. Smith, L. J. L. Angus, D. J. Hilton, N. A. Nicola, J. Wijdenes, and R. J. Simpson (1998)
J. Biol. Chem.
273, 22701-22707
| Abstract »
| Full Text »
| PDF »
- The Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Is a Nanomolar Affinity Receptor for Glycosylated Human Leukemia Inhibitory Factor.
- F. Blanchard, S. Raher, L. Duplomb, P. Vusio, V. Pitard, J.-L. Taupin, J.-F. Moreau, B. Hoflack, S. Minvielle, Y. Jacques, et al. (1998)
J. Biol. Chem.
273, 20886-20893
| Abstract »
| Full Text »
| PDF »
- Cytokine-Like Factor-1, a Novel Soluble Protein, Shares Homology with Members of the Cytokine Type I Receptor Family.
- G. C. A. Elson, P. Graber, C. Losberger, S. Herren, D. Gretener, L. N. Menoud, T. N. C. Wells, M. H. Kosco-Vilbois, and J.-F. Gauchat (1998)
J. Immunol.
161, 1371-1379
| Abstract »
| Full Text »
| PDF »
- Pituitary Corticotroph SOCS-3: Novel Intracellular Regulation of Leukemia-Inhibitory Factor-Mediated Proopiomelanocortin Gene Expression and Adrenocorticotropin Secretion.
- C. J. Auernhammer, V. Chesnokova, C. Bousquet, and S. Melmed (1998)
Mol. Endocrinol.
12, 954-961
| Abstract »
| Full Text »
- Cloning and Characterization of a Specific Receptor for Mouse Oncostatin M.
- R. A. Lindberg, T. S.-C. Juan, A. A. Welcher, Y. Sun, R. Cupples, B. Guthrie, and F. A. Fletcher (1998)
Mol. Cell. Biol.
18, 3357-3367
| Abstract »
| Full Text »
- Identification and Characterization of Two Distinct Truncated Forms of gp130 and a Soluble Form of Leukemia Inhibitory Factor Receptor alpha -Chain in Normal Human Urine and Plasma.
- J.-G. Zhang, Y. Zhang, C. M. Owczarek, L. D. Ward, R. L. Moritz, R. J. Simpson, K. Yasukawa, and N. A. Nicola (1998)
J. Biol. Chem.
273, 10798-10805
| Abstract »
| Full Text »
| PDF »
- Oncostatin M Down-regulates Basal and Induced Cytochromes P450 in Human Hepatocytes.
- M. I. Guillén, M. T. Donato, R. Jover, J. V. Castell, R. Fabra, R. Trullenque, and M. J. Gómez-Lechón (1998)
J. Pharmacol. Exp. Ther.
285, 127-134
| Abstract »
| Full Text »
- Oncostatin M Is a Potent Stimulator of alpha 1-Antitrypsin Secretion in Lung Epithelial Cells: Modulation by Transforming Growth Factor-beta and Interferon-gamma.
- A. Boutten, P. Venembre, N. Seta, J. Hamelin, M. Aubier, G. Durand, and M. S. Dehoux (1998)
Am. J. Respir. Cell Mol. Biol.
18, 511-520
| Abstract »
| Full Text »
- Sympathetic neurons can produce and respond to interleukin 6.
- P. Marz, J.-G. Cheng, R. A. Gadient, P. H. Patterson, T. Stoyan, U. Otten, and S. Rose-John (1998)
PNAS
95, 3251-3256
| Abstract »
| Full Text »
| PDF »
- STAT3 Acts as a Co-activator of Glucocorticoid Receptor Signaling.
- Z. Zhang, S. Jones, J. S. Hagood, N. L. Fuentes, and G. M. Fuller (1997)
J. Biol. Chem.
272, 30607-30610
| Abstract »
| Full Text »
| PDF »
- Transmembrane Domain of gp130 Contributes to Intracellular Signal Transduction in Hepatic Cells.
- H. Kim and H. Baumann (1997)
J. Biol. Chem.
272, 30741-30747
| Abstract »
| Full Text »
| PDF »
- Synergistic Action of Flt3 and gp130 Signalings in Human Hematopoiesis.
- Y. Ebihara, K. Tsuji, S. D. Lyman, X. Sui, M. Yoshida, K. Muraoka, K. Yamada, R. Tanaka, and T. Nakahata (1997)
Blood
90, 4363-4368
| Abstract »
| Full Text »
| PDF »
- Recombinant Soluble Interleukin-11 (IL-11) Receptor alpha -Chain Can Act as an IL-11 Antagonist.
- D. J. Curtis, D. J. Hilton, B. Roberts, L. Murray, N. Nicola, and C. G. Begley (1997)
Blood
90, 4403-4412
| Abstract »
| Full Text »
| PDF »
- A Sweat Gland-derived Differentiation Activity Acts through Known Cytokine Signaling Pathways.
- B. A. Habecker, A. J. Symes, N. Stahl, N. J. Francis, A. Economides, J. S. Fink, G. D. Yancopoulos, and S. C. Landis (1997)
J. Biol. Chem.
272, 30421-30428
| Abstract »
| Full Text »
| PDF »
- Leukemia Inhibitory Factor, a Potent Cardiac Hypertrophic Cytokine, Activates the JAK/STAT Pathway in Rat Cardiomyocytes.
- H. Kodama, K. Fukuda, J. Pan, S. Makino, A. Baba, S. Hori, and S. Ogawa (1997)
Circ. Res.
81, 656-663
| Abstract »
| Full Text »
- Identification of an Upstream Enhancer within a Functional Promoter of the Human Leukemia Inhibitory Factor Receptor Gene and Its Alternative Promoter Usage.
- Z. Wang and S. Melmed (1997)
J. Biol. Chem.
272, 27957-27965
| Abstract »
| Full Text »
| PDF »
- An Antagonist for the Leukemia Inhibitory Factor Receptor Inhibits Leukemia Inhibitory Factor, Cardiotrophin-1, Ciliary Neurotrophic Factor, and Oncostatin M.
- A. B. Vernallis, K. R. Hudson, and J. K. Heath (1997)
J. Biol. Chem.
272, 26947-26952
| Abstract »
| Full Text »
| PDF »
- The Unusual Species Cross-reactivity of the Leukemia Inhibitory Factor Receptor alpha -Chain Is Determined Primarily by the Immunoglobulin-like Domain.
- C. M. Owczarek, Y. Zhang, M. J. Layton, D. Metcalf, B. Roberts, and N. A. Nicola (1997)
J. Biol. Chem.
272, 23976-23985
| Abstract »
| Full Text »
| PDF »
- Ciliary Neurotrophic Factor Stimulates the Phosphorylation of Two Forms of STAT3 in Chick Ciliary Ganglion Neurons.
- M. A. Wishingrad, S. Koshlukova, and S. W. Halvorsen (1997)
J. Biol. Chem.
272, 19752-19757
| Abstract »
| Full Text »
| PDF »
- Distinct Roles for Leukemia Inhibitory Factor Receptor alpha -Chain and gp130 in Cell Type-specific Signal Transduction.
- R. Starr, U. Novak, T. A. Willson, M. Inglese, V. Murphy, W. S. Alexander, D. Metcalf, N. A. Nicola, D. J. Hilton, and M. Ernst (1997)
J. Biol. Chem.
272, 19982-19986
| Abstract »
| Full Text »
| PDF »
- HNMP-1: A Novel Hematopoietic and Neural Membrane Protein Differentially Regulated in Neural Development and Injury.
- L. M. Bolin, T. McNeil, L. A. Lucian, B. DeVaux, K. Franz-Bacon, D. M. Gorman, S. Zurawski, R. Murray, and T. K. McClanahan (1997)
J. Neurosci.
17, 5493-5502
| Abstract »
| Full Text »
| PDF »
- Oncostatin M and Leukemia Inhibitory Factor Do Not Use the Same Functional Receptor in Mice.
- M. Ichihara, T. Hara, H. Kim, T. Murate, and A. Miyajima (1997)
Blood
90, 165-173
| Abstract »
| Full Text »
| PDF »
- Box 3-independent Signaling Mechanisms Are Involved in Leukemia Inhibitory Factor Receptor alpha - and gp130-mediated Stimulation of Mitogen-activated Protein Kinase. EVIDENCE FOR PARTICIPATION OF MULTIPLE SIGNALING PATHWAYS WHICH CONVERGE AT Ras.
- W. P. Schiemann, J. L. Bartoe, and N. M. Nathanson (1997)
J. Biol. Chem.
272, 16631-16636
| Abstract »
| Full Text »
| PDF »
- Signaling of Type II Oncostatin M Receptor.
- P. Auguste, C. Guillet, M. Fourcin, C. Olivier, J. Veziers, A. Pouplard-Barthelaix, and H. Gascan (1997)
J. Biol. Chem.
272, 15760-15764
| Abstract »
| Full Text »
| PDF »
- Influence of Subunit Combinations on Signaling by Receptors for Oncostatin M, Leukemia Inhibitory Factor, and Interleukin-6.
- K. K. Kuropatwinski, C. De Imus, D. Gearing, H. Baumann, and B. Mosley (1997)
J. Biol. Chem.
272, 15135-15144
| Abstract »
| Full Text »
| PDF »
- Integration of Jak-Stat and AP-1 Signaling Pathways at the Vasoactive Intestinal Peptide Cytokine Response Element Regulates Ciliary Neurotrophic Factor-dependent Transcription.
- A. Symes, T. Gearan, J. Eby, and J. S. Fink (1997)
J. Biol. Chem.
272, 9648-9654
| Abstract »
| Full Text »
| PDF »
- Biosynthesis of alpha 1-Proteinase Inhibitor by Human Lung-derived Epithelial Cells.
- J. Cichy, J. Potempa, and J. Travis (1997)
J. Biol. Chem.
272, 8250-8255
| Abstract »
| Full Text »
| PDF »
- Impairment of antigen-specific antibody production in transgenic mice expressing a dominant-negative form of gp130.
- A. Kumanogoh, S. Marukawa, T. Kumanogoh, H. Hirota, K. Yoshida, I.-S. Lee, T. Yasui, K. Yoshida, T. Taga, and T. Kishimoto (1997)
PNAS
94, 2478-2482
| Abstract »
| Full Text »
| PDF »
- Signaling of the Cardiotrophin-1 Receptor. EVIDENCE FOR A THIRD RECEPTOR COMPONENT.
- O. Robledo, M. Fourcin, S. Chevalier, C. Guillet, P. Auguste, A. Pouplard-Barthelaix, D. Pennica, and H. Gascan (1997)
J. Biol. Chem.
272, 4855-4863
| Abstract »
| Full Text »
| PDF »
- Interleukin (IL)-6 Directs the Differentiation of IL-4-producing CD4+ T Cells.
- M. Rincon, J. Anguita, T. Nakamura, E. Fikrig, and R. A. Flavell (1997)
J. Exp. Med.
185, 461-470
| Abstract »
| Full Text »
| PDF »
- Activating Mutations in Cytokine Receptors: Implications for Receptor Function and Role in Disease.
- T. J. Gonda and R. J. D'Andrea (1997)
Blood
89, 355-369
| Full Text »
| PDF »
- Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology.
- E. Wijelath, B Carlsen, T Cole, J Chen, S Kothari, and W. Hammond (1997)
J. Cell Sci.
110, 871-879
| Abstract »
| PDF »
- Dual Oncostatin M (OSM) Receptors. CLONING AND CHARACTERIZATION OF AN ALTERNATIVE SIGNALING SUBUNIT CONFERRING OSM-SPECIFIC RECEPTOR ACTIVATION.
- B. Mosley, C. De Imus, D. Friend, N. Boiani, B. Thoma, L. S. Park, and D. Cosman (1996)
J. Biol. Chem.
271, 32635-32643
| Abstract »
| Full Text »
| PDF »
- Functional Expression of Soluble Human Interleukin-11 (IL-11) Receptor alpha and Stoichiometry of in Vitro IL-11 Receptor Complexes with gp130.
- P. Neddermann, R. Graziani, G. Ciliberto, and G. Paonessa (1996)
J. Biol. Chem.
271, 30986-30991
| Abstract »
| Full Text »
| PDF »
|
|